Introducing a new drug into your practice.
Many consultations in family practice end with a prescription for medication. The average market life of a new drug is only five years. Keeping up to date on therapeutic advances is an essential CME activity. Family physicians usually hear about new drugs from the pharmaceutical representatives. Before one changes well-established habits of practice it is necessary to evaluate non-commercial sources of data. A good understanding of the implications of clinical trials is required. The availability and accuracy of other sources of information are discussed.
W H
WH
Palmer
D L
DL
Ross
N Engl J Med. 1986 Jun 26;314(26):1657-64
3520318
N Y State J Med. 1981 Feb;81(2):195-8
6936633
Soc Sci Med. 1975 Feb;9(2):111-6
1093256
J R Coll Gen Pract. 1975 May;25(154):383-6
1177233
Am J Med. 1984 Sep;77(3):533-6
6475992
Soc Sci Med. 1984;18(12):1019-25
6463670
N Engl J Med. 1983 Dec 8;309(23):1426-34
6355851